Rapid RV/LV vs Tempus ECG-Low EF
AI Verdict
Choose Rapid RV/LV if…
Choose Rapid RV/LV if your clinical workflow requires immediate, objective quantification of pulmonary embolism severity from CTPA scans. This tool is ideal for emergency departments or critical care units needing to rapidly assess right ventricular strain to guide treatment decisions and patient triage for suspected or confirmed PE cases.
View Rapid RV/LV →Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if you need an AI-powered solution to screen for signs of low left ventricular ejection fraction (LVEF ≤40%) in patients 40 years or older using standard 12-lead ECGs. This is particularly useful in primary care, emergency medicine, or cardiology settings to identify at-risk patients who may benefit from further cardiac evaluation for heart failure.
View Tempus ECG-Low EF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Rapid RV/LV | Tempus ECG-Low EF |
|---|---|---|
| Pricing | Contact vendor for pricing information. | Unknown |
| Deployment | Unknown | Integrates with current ECG platforms and electronic health records (EHRs). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Rapid RV/LVRapid RV/LV (Tool A) provides annotated images with ventricular measurements and integrates into a broader platform with triage and notification capabilities, suggesting a more visually intuitive and comprehensive workflow for clinicians. Tempus ECG-Low EF (Tool B) offers a binary output, which is straightforward but may require more manual follow-up for interpretation and action.
Clinical Value
Rapid RV/LVBoth tools are FDA-cleared and address significant clinical needs. Rapid RV/LV (Tool A) offers rapid assessment of pulmonary embolism severity and reduces inter-rater variability, which is crucial for acute, time-sensitive decision-making in critical care. While Tempus ECG-Low EF (Tool B) aids in identifying patients at risk of heart failure, Tool A's immediate impact on acute treatment pathways provides a slight edge in direct clinical utility.
Pricing & Value
TieBoth Rapid RV/LV (Tool A) and Tempus ECG-Low EF (Tool B) require contacting the vendor for pricing information. Without specific pricing details or publicly available cost-benefit analyses, it is not possible to compare their value propositions directly.
Enterprise Readiness
Rapid RV/LVBoth tools are FDA-cleared, HIPAA compliant, and offer Business Associate Agreements (BAAs), which are essential for enterprise adoption. Rapid RV/LV (Tool A) explicitly offers flexible deployment options (on-premises or hybrid) and integrates with a broader Rapid platform, indicating a more detailed and robust approach to enterprise integration and scalability for diverse IT environments.
Innovation
Tempus ECG-Low EFBoth tools leverage AI in innovative ways for diagnostic support. Rapid RV/LV (Tool A) automates a critical and often subjective measurement from CTPA scans. However, Tempus ECG-Low EF (Tool B)'s application of AI to analyze 12-lead ECG recordings for detecting signs associated with low left ventricular ejection fraction (LVEF) is particularly innovative, as it extracts complex patterns from a non-imaging modality to identify a condition typically diagnosed with echocardiography, and is trained on a massive dataset of over 930,000 ECGs from 170,000+ patients.
Support & Docs
Rapid RV/LVRapidAI (Tool A) explicitly states offering '24/7/365 customer support' and a 'dedicated customer success team', indicating a strong commitment to ongoing assistance. While Tempus AI (Tool B) generally provides customer support for its offerings, specific details regarding the availability and depth of support for the ECG-Low EF product are not as prominently detailed in general public information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Rapid RV/LV | Tempus ECG-Low EF |
|---|---|---|
| Tool Name | Rapid RV/LV | Tempus ECG-Low EF |
| Company | RapidAI (formerly iSchemaView) | Tempus AI |
| Description | FDA-cleared AI tool for rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. | FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation. |
| Primary Function | Automated measurement of right and left ventricle diameters and calculation of RV/LV ratio from CTPA images for pulmonary embolism severity assessment. | AI-powered algorithm for ECG analysis to detect signs of low Left Ventricular Ejection Fraction (LVEF u226440%) in patients 40+ years at risk of heart failure. |
| Input Data | CTPA scans | 12-lead ECG recordings |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Emergency Medicine, Internal Medicine |
| Key Output | RV/LV ratio, annotated images showing ventricular measurements, rapid results (within minutes of scan). | Binary output (Low LVEF Detected / Not Detected) |
Videos
Demos, reviews, and walkthroughs featuring Rapid RV/LV and Tempus ECG-Low EF.
Frequently Asked Questions
More Comparisons
More matchups featuring Rapid RV/LV or Tempus ECG-Low EF
Backers
Who funded each tool's parent company.